Study on government's controversial choice of HPV vaccine

The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study published on BMJ.com today.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news135573621.html">Study on government's controversial choice of HPV vaccine</a></p> <p>The UK government may save up to £18.6 million a year by deciding to use the HPV vaccine Cervarix, given that it is equally effective as the more expensive Gardasil in preventing cervical abnormalities, according to a study published on BMJ.com today. </p>